Volume 54, Issue 3, Pages (September 1998)

Slides:



Advertisements
Similar presentations
Volume 65, Issue 1, Pages (January 2004)
Advertisements

Volume 60, Issue 3, Pages (September 2001)
Volume 64, Issue 6, Pages (December 2003)
Volume 65, Issue 1, Pages (January 2004)
Volume 54, Issue 5, Pages (November 1998)
Osteopontin expression in human crescentic glomerulonephritis
Volume 54, Issue 6, Pages (January 1998)
Volume 78, Issue 4, Pages (August 2010)
Volume 70, Issue 4, Pages (August 2006)
Volume 63, Issue 6, Pages (June 2003)
Volume 54, Issue 1, Pages (July 1998)
Volume 81, Issue 9, Pages (May 2012)
Volume 57, Issue 4, Pages (April 2000)
Volume 57, Issue 2, Pages (October 2000)
Volume 67, Issue 3, Pages (March 2005)
IN-1130, a novel transforming growth factor-β type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy  J.-A. Moon,
Volume 65, Issue 1, Pages (January 2004)
Volume 60, Issue 2, Pages (August 2001)
Volume 70, Issue 7, Pages (October 2006)
Volume 81, Issue 9, Pages (May 2012)
Volume 61, Issue 5, Pages (May 2002)
Volume 66, Issue 6, Pages (December 2004)
Volume 62, Issue 6, Pages (December 2002)
Volume 81, Issue 3, Pages (February 2012)
Kameswaran Surendran, Theodore C. Simon, Helen Liapis, John K. McGuire 
In situ localization and quantification of seventy-two – kilodalton type IV collagenase in aneurysmal, occlusive, and normal aorta  William D. McMillan,
Volume 57, Issue 6, Pages (June 2000)
Volume 54, Issue 3, Pages (September 1998)
Volume 63, Issue 4, Pages (April 2003)
Tubular NF-κB and AP-1 activation in human proteinuric renal disease
Volume 59, Issue 5, Pages (May 2001)
Volume 59, Issue 4, Pages (April 2001)
Endogenous hepatocyte growth factor ameliorates chronic renal injury by activating matrix degradation pathways  Youhua Liu, Krupa Rajur, Evelyn Tolbert,
Volume 61, Issue 5, Pages (May 2002)
Volume 56, Issue 3, Pages (September 1999)
The renal lesions that develop in neonatal mice during angiotensin inhibition mimic obstructive nephropathy  Yoichi Miyazaki, Shinya Tsuchida, Agnes Fogo,
Volume 54, Issue 5, Pages (November 1998)
Volume 60, Issue 3, Pages (September 2001)
Volume 62, Issue 4, Pages (October 2002)
Volume 58, Issue 3, Pages (September 2000)
Volume 63, Issue 2, Pages (February 2003)
Volume 57, Issue 1, Pages (January 2000)
Magnus Åbrink, Eric Larsson, Anders Gobl, Lars Hellman 
Volume 81, Issue 3, Pages (February 2012)
Volume 62, Issue 2, Pages (August 2002)
Volume 61, Issue 6, Pages (June 2002)
Tight blood pressure control decreases apoptosis during renal damage
Volume 60, Issue 6, Pages (December 2001)
Volume 57, Issue 3, Pages (March 2000)
Volume 63, Issue 4, Pages (April 2003)
Wei-Zhong Ying, Pei-Xuan Wang, Paul W. Sanders  Kidney International 
Volume 59, Issue 3, Pages (March 2001)
Caspase-3 and apoptosis in experimental chronic renal scarring
Volume 65, Issue 2, Pages (February 2004)
Expression of connective tissue growth factor in human renal fibrosis
Volume 63, Issue 2, Pages (February 2003)
Effect of nitric oxide modulation on TGF-β1 and matrix proteins in chronic cyclosporine nephrotoxicity  Fuad S. Shihab, Hong Yi, William M. Bennett, Takeshi.
Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis  H.-C. Yang, L.-J. Ma, J. Ma, A.B. Fogo 
Volume 56, Issue 5, Pages (November 1999)
M.-J. Wu, M.-C. Wen, Y.-T. Chiu, Y.-Y. Chiou, K.-H. Shu, M.-J. Tang 
Volume 55, Issue 6, Pages (June 1999)
Volume 58, Issue 4, Pages (October 2000)
Volume 56, Issue 6, Pages (December 1999)
Volume 59, Issue 2, Pages (February 2001)
Volume 65, Issue 2, Pages (February 2004)
Volume 73, Issue 5, Pages (March 2008)
Volume 72, Issue 11, Pages (December 2007)
J. Ma, A. Weisberg, J.P. Griffin, D.E. Vaughan, A.B. Fogo, N.J. Brown 
Volume 65, Issue 1, Pages (January 2004)
Volume 75, Issue 2, Pages (January 2009)
Presentation transcript:

Volume 54, Issue 3, Pages 804-818 (September 1998) Inhibition of the matrix metalloproteinase system in a rat model of chronic cyclosporine nephropathy  Carla Duymelinck, Jing-Ti Deng, Simonne E.H. Dauwe, Marc E. De Broe, Gert A. Verpooten  Kidney International  Volume 54, Issue 3, Pages 804-818 (September 1998) DOI: 10.1046/j.1523-1755.1998.00050.x Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 1 (upper panels). Immunohistochemical α-smooth muscle actin (α-SMA) staining. (A) In the salt-depleted vehicle-treated rat very few interstitial cells are α-SMA positive. (B) After CsA treatment (20mg CsA/kg body wt, 3weeks) foci of α-SMA expressing interstitial cells are located peritubularly in the subcapsular and deeper cortex. Magnification ×422. The publication of this figure in color was made possible, in part, by a grant from Novartis Pharma Belgium. Kidney International 1998 54, 804-818DOI: (10.1046/j.1523-1755.1998.00050.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 2 (middle panels). Combined PCNA/ED1 immunohistochemical staining. A microwave-based dual-labeling immunohistochemical technique was used to stain for both proliferating cells (PCNA, brown nuclear staining) and macrophages (ED1, black cytoplasmic staining). (A) In kidneys of control rats a limited number of PCNA positive nuclei were found in tubules and in the interstitium. Macrophages were absent. (B) In CsA-treated rats (20mg CsA/kg body wt, 3weeks) PCNA positive nuclei were associated with focal damaged areas, while adjacent intact areas contained few proliferating cells. Macrophages were even more evidently associated with fibrotic foci. (C) Detail of panel B. Cellular proliferation is pronounced in injured (vacuolized, dilated and atrophic) tubules and in the interstitium. Macrophages surround atrophic tubules and infiltrate the glomerular tuft. The increased number of macrophages in CsA-treated rats is not only due to infiltration but also due to proliferation as a subpopulation of macrophages is PCNA positive (arrows). Magnification for A and B ×105; for C, ×422. The publication of this figure in color was made possible, in part, by a grant from Novartis Pharma Belgium. Kidney International 1998 54, 804-818DOI: (10.1046/j.1523-1755.1998.00050.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 3 Quantification of cellular proliferation in the cortex. Proliferation was quantified separately in damaged tubules (atrophy, dilation, vacuolization; A), in intact tubules (B), in the cortical interstitium (C) and in glomeruli. Results are expressed as number of PCNA positive nuclei per mm2 cortex. Symbols are: (▬) mean; (•) individual measurement. *P < 0.05. PCNA positivity was much less pronounced in the glomerular compartment: per glomerulus 0.6±0.2; 0.6±0.2; 1.1±0.5 and 2.5±2.0 PCNA positive nuclei were counted in the vehicle-treated, 10, 15 and 20mg CsA/kg body wt groups, respectively. All data, except PCNA positivity in healthy tubules, were analyzed with ANOVA followed by post-hoc Student-Newman-Keuls testing. Kidney International 1998 54, 804-818DOI: (10.1046/j.1523-1755.1998.00050.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 4 (lower panels). Immunohistochemical PAI-1 staining. (A) In vehicle-treated sodium-depleted rats, PAI-1 was mainly found in small vesicles (lysosomes) in proximal tubular cells and in visceral epithelium of glomeruli. (B) In renal sections of CsA-treated rats (15mg CsA/kg body wt, 3weeks) enlarged PAI-1 positive vesicles were observed in atrophic tubules (arrows). Magnification ×338. The publication of this figure in color was made possible, in part, by a grant from Novartis Pharma Belgium. Kidney International 1998 54, 804-818DOI: (10.1046/j.1523-1755.1998.00050.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 5 Northern blot and densitometric analysis of whole kidney RNA for interstitial collagenase (A) and stromelysin (B) expression. The injected CsA dose is shown under the densitometry graphs. The autoradiograph of GAPDH shows the amount of RNA loaded. Densitometric analyses of the autoradiographs corrected for any RNA loading errors are represented in the bar graphs. Results are expressed as mean±sd. Data were analyzed with the Kruskal-Wallis ANOVA. Kidney International 1998 54, 804-818DOI: (10.1046/j.1523-1755.1998.00050.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 6 Northern blot and densitometric analysis of whole kidney RNA for tissue inhibitor of matrix metalloproteinases (TIMP-1) expression. The injected CsA dose is shown under the densitometry graphs. The autoradiograph of GAPDH shows the amount of RNA loaded. Densitometric analysis of the autoradiograph corrected for any RNA loading errors is represented in the bar graphs. Results are expressed as mean±sd. Data were analyzed with the Kruskal-Wallis ANOVA, and group-to-group comparisons were made with the Mann-Whitney U-test (*P < 0.05; significantly different from the CsA-treated groups). Kidney International 1998 54, 804-818DOI: (10.1046/j.1523-1755.1998.00050.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 7 In situ hybridization (ISH) for TIMP-1 mRNA (A, B, D, E, F) and control hybridization to verify the specificity of the signal (C). (A) ISH of kidneys of vehicle-treated salt-depleted rats (3weeks) with the TIMP-1 antisense probe revealed no TIMP-1 transcribing cells. (B) ISH with the antisense TIMP-1 probe of renal sections from CsA-treated rats (15mg CsA/kg body wt, 5weeks) shows that interstitial cells in damaged areas are the main site of TIMP-1 gene transcription. TIMP-1 mRNA is also expressed by glomerular cells. (D; detail of B) TIMP-1 expressing interstitial cells were mainly present in injured areas in the vicinity of damaged tubules or in the widened interstitial space (arrow). (E; detail of B) In adjacent intact areas, TIMP-1 transcribing interstitial and glomerular cells were sparse or absent. (F) Glomerular TIMP expressing cells included epithelial cells of Bowman's capsule (black arrow) and visceral epithelial cells (open arrow). (C) In each hybridization, consecutive sections were hybridized with sense TIMP-1 riboprobe to assess for aspecific probe adhesion to renal tissue. ISH signals were not observed in any of the negative controls. Magnification A-C, ×105; D, E, ×422; F, ×675. The publication of this figure in color was made possible, in part, by a grant from Novartis Pharma, Belgium. Kidney International 1998 54, 804-818DOI: (10.1046/j.1523-1755.1998.00050.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Kidney International 1998 54, 804-818DOI: (10. 1046/j. 1523-1755. 1998 Kidney International 1998 54, 804-818DOI: (10.1046/j.1523-1755.1998.00050.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Kidney International 1998 54, 804-818DOI: (10. 1046/j. 1523-1755. 1998 Kidney International 1998 54, 804-818DOI: (10.1046/j.1523-1755.1998.00050.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Kidney International 1998 54, 804-818DOI: (10. 1046/j. 1523-1755. 1998 Kidney International 1998 54, 804-818DOI: (10.1046/j.1523-1755.1998.00050.x) Copyright © 1998 International Society of Nephrology Terms and Conditions